CS414091A3 - Condensed benzazepines - Google Patents

Condensed benzazepines Download PDF

Info

Publication number
CS414091A3
CS414091A3 CS914140A CS414091A CS414091A3 CS 414091 A3 CS414091 A3 CS 414091A3 CS 914140 A CS914140 A CS 914140A CS 414091 A CS414091 A CS 414091A CS 414091 A3 CS414091 A3 CS 414091A3
Authority
CS
Czechoslovakia
Prior art keywords
hydrogen
alkyl
hydroxy
methyl
benzo
Prior art date
Application number
CS914140A
Other languages
Czech (cs)
English (en)
Inventor
Joel G Berger
Wei K Chang
Elijah H Gold
John W Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CS414091A3 publication Critical patent/CS414091A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS914140A 1986-01-16 1991-12-30 Condensed benzazepines CS414091A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82047186A 1986-01-16 1986-01-16

Publications (1)

Publication Number Publication Date
CS414091A3 true CS414091A3 (en) 1992-05-13

Family

ID=25230864

Family Applications (1)

Application Number Title Priority Date Filing Date
CS914140A CS414091A3 (en) 1986-01-16 1991-12-30 Condensed benzazepines

Country Status (19)

Country Link
EP (2) EP0254737B1 (ko)
JP (1) JPH0681745B2 (ko)
KR (1) KR900007781B1 (ko)
AU (1) AU588080B2 (ko)
CA (1) CA1333485C (ko)
CS (1) CS414091A3 (ko)
DK (1) DK164161C (ko)
ES (1) ES2031834T3 (ko)
FI (1) FI83512C (ko)
GR (1) GR3000994T3 (ko)
HU (1) HU199805B (ko)
IE (1) IE59651B1 (ko)
IL (2) IL103007A (ko)
NZ (1) NZ218953A (ko)
OA (1) OA08660A (ko)
PT (1) PT84109B (ko)
SG (1) SG128692G (ko)
WO (1) WO1987004430A2 (ko)
ZA (1) ZA87291B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
DE3780649T2 (de) * 1987-07-15 1992-12-10 Schering Corp Kondensierte benzazepine.
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
JPH03505735A (ja) * 1988-07-29 1991-12-12 シェリング・コーポレーション ヘキサヒドロ―ベンゾ［ｄ］―ナフト［２，１―ｂ］アゼピンのための中間体の対掌体特異的合成のための方法
US5091526A (en) * 1988-07-29 1992-02-25 Schering Corporation Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines
US5104814A (en) * 1988-11-22 1992-04-14 Schering Corporation Assay kit and methods for neuroleptic drugs
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
CA2075181C (en) * 1990-02-02 1997-12-09 Theodros Asberom 4,5-bridged-2,3,4,5-tetrahydro-1h-3-benzazepine-7-ols
US5461147A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5461148A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5463051A (en) * 1993-09-27 1995-10-31 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
AR027687A1 (es) 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
MXPA05002249A (es) * 2002-08-29 2005-06-08 Schering Corp Antagonistas selectivos del receptor d1/d5 para el tratamiento de obesidad y trastornos del sistema nervioso central.
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体
US8586634B2 (en) 2007-06-15 2013-11-19 University Of Florida Research Foundation, Inc. Therapeutic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US3609138A (en) 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
NL7206203A (ko) * 1971-05-10 1972-11-14
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride
US4011319A (en) 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
US4284555A (en) 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

Also Published As

Publication number Publication date
FI83512C (fi) 1991-07-25
FI874006A0 (fi) 1987-09-15
HUT48600A (en) 1989-06-28
EP0254737B1 (en) 1990-07-25
IE59651B1 (en) 1994-03-09
AU6892087A (en) 1987-08-14
DK479087A (da) 1987-09-14
KR880700794A (ko) 1988-04-12
ZA87291B (en) 1987-11-25
DK164161C (da) 1992-10-26
EP0230270B1 (en) 1990-08-01
EP0254737A1 (en) 1988-02-03
DK164161B (da) 1992-05-18
IL103007A (en) 1993-07-08
AU588080B2 (en) 1989-09-07
FI83512B (fi) 1991-04-15
IL81268A0 (en) 1987-08-31
JPS63502348A (ja) 1988-09-08
OA08660A (en) 1988-11-30
PT84109B (pt) 1989-07-31
GR3000994T3 (en) 1991-12-10
NZ218953A (en) 1990-03-27
EP0230270A2 (en) 1987-07-29
JPH0681745B2 (ja) 1994-10-19
WO1987004430A3 (en) 1988-03-24
SG128692G (en) 1993-03-12
ES2031834T3 (es) 1993-01-01
IE870112L (en) 1987-07-16
KR900007781B1 (ko) 1990-10-20
WO1987004430A2 (en) 1987-07-30
PT84109A (en) 1987-02-01
EP0230270A3 (en) 1987-10-21
CA1333485C (en) 1994-12-13
DK479087D0 (da) 1987-09-14
HU199805B (en) 1990-03-28
FI874006A (fi) 1987-09-15

Similar Documents

Publication Publication Date Title
CS414091A3 (en) Condensed benzazepines
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
US5296482A (en) (Benzocycloalkyl) alkylamines
US5530125A (en) Synthesis of α-substituted-aryl ethylamines
JPH0819065B2 (ja) ベンゾ融合シクロアルカンおよびオキサ‐およびチア‐シクロアルカントランス‐１，２‐ジアミン誘導体
EP0096838A1 (en) 1-Aryloxy-2,3,4,5-tetrahydro-3-benzazepines, a process for preparing the same and their use as medicaments
US4973586A (en) Fused benzazepines, compositions of, and medical use thereof
IE912031A1 (en) 8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substituted¹benzazepines and pharmaceutical compositions containing them
KR100213531B1 (ko) 헥사히드로아제핀 유도체, 그것들의 제법과 그것들을 함유하는 약학 조성물
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
WO1991011437A1 (en) 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
KOJIMA et al. Syntheses of (±)-2-[(inden-7-yloxy) methyl] morpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral-activating and antidepressive properties
FI88800B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin- eller -1,4-bensoxazonin-foereningar samt mellanprodukter
EP0363353B1 (en) Fused benzazepines
US5302716A (en) Fused benzazepines
JP2007509094A (ja) Ｍａｏ−ｂ阻害物質としてのベンズアゼピン誘導体
FI64142C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinonderivat
IE60925B1 (en) Fused benzazepines